Thermo Fisher Scientific | TMO - Ativo Circulante





Ativo Circulante Alterar Data
Abbott USD 23.5B 1.02B 2026-09
Agilent USD 4.69B 70M 2026-06
Becton, Dickinson and Co. USD 8.32B 178M 2026-09
Bio Techne USD 824.83M 80.43M 2026-09
Bio-Rad Laboratories USD 3.08B 58.1M 2026-09
Boston Scientific USD 8.16B 192M 2026-09
Bruker USD 2.16B 67.9M 2026-09
Charles River Laboratories USD 1.54B 5.92M 2026-09
Danaher USD 14.79B 1.41B 2026-09
Dentsply International USD 1.98B 50M 2026-09
Edwards Lifesciences USD 7.25B 428.6M 2026-09
General Electric Aerospace USD 41.53B 1.83B 2026-09
Henry Schein USD 4.78B 176M 2026-09
Illumina USD 3.04B 201M 2026-09
Intuitive Surgical USD 10.65B 1.68B 2026-09
IQVIA Holdings USD 6.45B 225M 2026-09
Laboratory Of America USD 3.97B 151.3M 2026-09
Medtronic USD 24.39B 397M 2026-06
Mettler Toledo International USD 1.38B 28.79M 2026-09
Myriad Genetics USD 289M 23.8M 2026-06
Olympus JPY 652.66B 15.18B 2026-09
OraSure Technologies USD 222.94M 17.84M 2026-06
Quest Diagnostics USD 3.12B 273M 2026-09
Repligen USD 1.24B 41.43M 2026-09
Revvity USD 1.86B 436.33M 2026-09
Stryker USD 14.18B 235M 2026-09
Thermo Fisher Scientific USD 25.62B 2.25B 2026-09
Veracyte USD 467.88M 106.9M 2026-09
Waters USD 3.9B 186M 2026-06
Zimmer Biomet Holdings USD 5.13B 32.3M 2026-09